IMU Biosciences
Latest round
- Series A
Last raised
- Jun 2026
Total raised
- $66M
Investors
- 5
About IMU Biosciences
Founded in 2019 and headquartered in London, United Kingdom, the company was co-founded by Adam Laing, Tom Hayday, and Mario Cantero., trading under the name IMU Biosciences, operates as a biotech company that develops an immunological atlas to treat a range of human health and disease. The firm develops and offers an immune discovery platform using AI/ML (artificial intelligence/machine learning) to develop precision medicines. The platform aids in the advancement of translational research and accelerates the drug development process in areas of cell therapy, immuno-oncology, transplantation, and autoimmunity.
Who invested in IMU Biosciences
5 investors across 2 rounds
See all investors in IMU Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about IMU Biosciences
Who invested in IMU Biosciences?
IMU Biosciences has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has IMU Biosciences raised?
IMU Biosciences has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did IMU Biosciences last raise money?
IMU Biosciences's most recent round on record is a Series A, in Jun 2026.
What does IMU Biosciences do?
Founded in 2019 and headquartered in London, United Kingdom, the company was co-founded by Adam Laing, Tom Hayday, and Mario Cantero.
Where is IMU Biosciences headquartered?
IMU Biosciences is headquartered in London, UK.
Which VCs invest in companies like IMU Biosciences?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at IMU Biosciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like IMU Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.